Scolaris Content Display Scolaris Content Display

مدیریت محافظه‌کارانه در مقابل مدیریت مداخله‌ای برای پنوموتوراکس خودبه‌خودی اولیه در بزرگسالان

Appendices

Appendix 1. CENTRAL (The Cochrane Library) search strategy

#1 MeSH descriptor: [Pneumothorax] explode all trees
#2 pneumothorax
#3 #1 or #2
#4 MeSH descriptor: [Thoracotomy] explode all trees
#5 MeSH descriptor: [Thoracostomy] explode all trees
#6 MeSH descriptor: [Chest Tubes] explode all trees
#7 MeSH descriptor: [Drainage] explode all trees
#8 MeSH descriptor: [Suction] explode all trees
#9 (aspiration or thoraco?tom* or suction):ti,ab or chest tube* or (drain* near/3 (chest or intercostal or thoracic))
#10 #4 or #5 or #6 or #7 or #8 or #9
#11 #3 and #10

Appendix 2. MEDLINE (Ovid SP) search strategy

1. exp Pneumothorax/ or pneumothorax.af.
2. exp Thoracotomy/ or exp Thoracostomy/ or exp Chest Tubes/ or Drainage/ or Suction/ or (aspiration or thoraco?tom* or suction).ti,ab. or chest tube*.mp. or (drain* adj3 (chest or intercostal or thoracic)).mp.
3. 1 and 2
4. ((randomized controlled trial or controlled clinical trial).pt. or randomized.ab. or placebo.ab. or clinical trials as topic.sh. or randomly.ab. or trial.ti.) not (animals not (humans and animals)).sh.
5. 3 and 4

Appendix 3. EMBASE (Ovid SP) search strategy

1. exp pneumothorax/ or pneumothorax.af.
2. thoracotomy/ or thorax drainage/ or chest tube/ or suction/ or (aspiration or thoraco?tom* or suction).ti,ab. or chest tube*.ti,ab. or drain* adj3 (chest or intercostal or thoracic)).ti,ab.
3. (placebo.sh. or controlled study.ab. or random*.ti,ab. or trial*.ti,ab. or ((singl* or doubl* or trebl* or tripl*) adj3 (blind* or mask*)).ti,ab.) not (animals not (humans and animals)).sh.
4. 1 and 2 and 3

Appendix 4. CINAHL (EBSCOhost) search strategy

S1 (MM "Pneumothorax") OR "Pneumothorax"
S2 ((MM "Thoracotomy") OR (MM "Chest Tubes") OR (MH "Drainage") OR (MH "Suction")) OR AB (aspiration or thoraco?tom* or suction) OR TI (aspiration or thoraco?tom* or suction) OR TX chest tube* OR ((drain* N3 (chest or intercostal or thoracic)))
S3 ((MM "Randomized Controlled Trials") OR (MM "Random Assignment") OR (MM "Prospective Studies+") OR (MM "Clinical Trial Registry") OR (MM "Double‐Blind Studies") OR (MM "Single‐Blind Studies") OR (MM "Triple‐Blind Studies") OR (MM "Multicenter Studies") OR (MM "Placebos")) OR (random* or placebo*)
S4 S1 AND S2 AND S3

Appendix 5. ISI Web of Science search strategy

#1 TS=pneumothorax
#2 TI=(aspiration or thoraco?tom* or suction) or TS=chest tube* or TS=(drain* SAME (chest or intercostal or thoracic))
#3 TS=(random* or ((controlled or clinical) SAME trial*) or placebo* or multicenter or prospective) or TS=((blind* or mask*) SAME (single or double or triple or treble))
#4 #3 AND #2 AND #1

Appendix 6. Screening form

Author

Title

Journal

Date vol page

Controlled/RCT

Pneumothorax

Conservative treatment

Exclude

Get full reference

 

 

 

 

2 author consensus

2 author consensus

2 author consensus

 

 

Appendix 7. Data Extraction Form

CARG

Data collection form

Intervention review

 

Notes on using a data extraction form:

  • Be consistent in the order and style you use to describe the information for each report

  • Record any missing information as unclear or not described, to make it clear that the information was not found in the study report(s), not that you forgot to extract it.

  • Include any instructions and decision rules on the data collection form, or in an accompanying document. It is important to practice using the form and give training to any other authors using the form.

 

Review title or ID

     

Study ID(surname of first author and year first full report of study was published e.g. Smith 2001)

     

Report IDs of other reports of this study(e.g. duplicate publications, follow‐up studies)

     

Notes:        

 

 

1.    General Information

 

Date form completed(dd/mm/yyyy)

     

Name/ID of person extracting data

     

 

Report title

(title of paper/ abstract/ report that data are extracted from)

     

 

Report ID

(ID for this paper/ abstract/ report)

     

 

Reference details

 

     

 

 

Report author contact details

     

 

Publication type

(e.g. full report, abstract, letter)

     

 

Study funding sources

(including role of funders)

     

 

Possible conflicts of interest

(for study authors)

     

 

Notes:      

 

 

2.    Study Eligibility

 

Study Characteristics

Eligibility criteria

(Insert eligibility criteria for each characteristic as defined in the Protocol)

Yes

No

Unclear

Location in text

(pg & ¶/fig/table)

Type of study

Randomized Controlled Trial

     

Controlled Clinical Trial

(quasi‐randomized trial)

     

Participants

 

     

 

 

     

Types of intervention

     

 

 

     

Types of outcome measures

     

 

 

     

INCLUDE 

EXCLUDE 

Reason for exclusion

 

     

Notes:        

 

 

DO NOT PROCEED IF STUDY EXCLUDED FROM REVIEW

3.    Population and setting

 

 

Description

Include comparative information for each group (i.e. intervention and controls) if available

Location in text

(pg & ¶/fig/table)

Population description

(from which study participants are drawn)

     

     

Setting

(including location and social context)

     

     

Inclusion criteria
Age ≥ 18

1st episode of spontaneous pneumothorax

Radiological evidence

     

     

Exclusion criteria
Underlying lung disease

Trauma

Other secondary cause

Recurrence

     

     

Informed consent obtained

 

            

Yes      No     Unclear

     

     

Notes:        

 

 

4.    Methods

 

 

Descriptions as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Aim of study

 

 

     

     

Design(e.g. parallel, crossover, cluster)

     

     

Unit of allocation

(by individuals, cluster/ groups or body parts)

     

     

Start date

 

     

 

     

End date

 

     

 

     

Total study duration

 

     

     

Ethical approval needed/ obtained for study

            

Yes      No     Unclear

     

     

Notes:        

 

 

5.    Risk of Bias assessment

See Chapter 8 of theHiggins 2011

 

Domain

Risk of bias

 

Support for judgement

 

Location in text

(pg & ¶/fig/table)

Low risk

High risk

Unclear

Random sequence generation

(selection bias)

     

     

Allocation concealment

(selection bias)

 

     

     

Blinding of participants and personnel

(performance bias)

Outcome group: All/     

     

     

(if required)

Outcome group:      

     

     

Blinding of outcome assessment

(detection bias)

Outcome group: All/     

     

     

(if required)

Outcome group:      

     

     

Incomplete outcome data

(attrition bias)

 

     

     

Selective outcome reporting?

(reporting bias)

     

     

Other bias

 

 

     

     

Notes:        

 

 

6.    Participants

Provide overall data and, if available, comparative data for each intervention or comparison group.

 

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Total no. randomized

(or total pop. at start of study for NRCTs)

     

     

Clusters

(if applicable, no., type, no. people per cluster)

     

     

Baseline imbalances

     

     

Withdrawals and exclusions

(if not provided below by outcome)

     

     

Age

     

     

Sex

     

     

Race/Ethnicity

     

     

Size of pneumothorax

     

     

Co‐morbidities

(should be excluded if co‐existent lung disease

 

     

     

Other treatment received(additional to study intervention)

     

     

Other relevant sociodemographics

 

     

     

Subgroups measured

Smoking

Other

 

     

     

Subgroups reported

Smoking

Other

     

     

Notes:        

 

 

7.    Intervention groups

Copy and paste table for each intervention and comparison group

 

Intervention Group 1

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Group name

Conservative or Interventional

 

     

     

No. randomized to group

(specify whether no. people or clusters)

     

     

Theoretical basis(include key references)

 

     

     

Description of intervention(include sufficient detail for replication, e.g. Type of supportive therapy  ‐ oxygen, analgesia etc; or type of intervention – chest tube, needle aspiration etc)

     

     

Duration of treatment period

     

     

Timing(e.g. frequency, duration of each episode)

     

     

Delivery(e.g. mechanism, medium, intensity, fidelity)

     

     

Providers

(e.g. type of hospital, specialty, training etc)

     

     

Co‐interventions

 

     

     

Economic variables
(i.e. intervention cost if available)

     

     

Notes:        

 

 

 

8.    Outcomes

Copy and paste table for each outcome.

 

Early recurrence

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Outcome name

Recurrence ‐ early

     

     

Time points measured

     

     

Time points reported

     

     

Outcome definition(with diagnostic criteria if relevant)

     

     

Person measuring/reporting

     

     

Imputation of missing data
(e.g. assumptions made for ITT analysis)

     

     

Assumed risk estimate

(e.g. baseline or population risk noted  in Background)

     

     

Power

No. with data in conservative mx group

N. with data in interventional group

     

     

Notes:        

 

 

 

Repeat for late recurrence

 

Mortality

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Outcome name

Mortality

 

     

     

Time points measured

     

     

Time points reported

     

     

Person measuring/reporting

     

     

Imputation of missing data
(e.g. assumptions made for ITT analysis)

     

     

Assumed risk estimate

(e.g. baseline or population risk noted  in Background)

     

     

Power

No. with data conservative

No. with data interventional

     

     

Notes:        

 

 

 

Length of hospital stay

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Outcome name

Length of hospital stay

     

     

Outcome definition

     

     

Person measuring/reporting

     

     

Unit of measurement

 

     

     

Imputation of missing data
(e.g. assumptions made for ITT analysis)

     

     

Assumed risk estimate

(e.g. baseline or population risk noted  in Background)

     

     

Power Number of participants with Data:

Conservative group

Interventional group

     

     

Notes:        

 

 

 

Pleurectomy or pleurodesis

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Outcome name

Pleurectomy or pleurodesis

 

     

     

Time points measured

     

     

Time points reported

     

     

Outcome definition

     

     

Person measuring/reporting

     

     

Imputation of missing data
(e.g. assumptions made for ITT analysis)

     

     

Assumed risk estimate

(e.g. baseline or population risk noted  in Background)

     

     

Power

No. with data conservative

No. with data interventional

     

     

Notes:        

 

 

 

Complications

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Outcome name

Complications

 

     

     

Time points measured

     

     

Time points reported

     

     

Outcome definition

     

     

Person measuring/reporting

     

     

Imputation of missing data
(e.g. assumptions made for ITT analysis)

     

     

Assumed risk estimate

(e.g. baseline or population risk noted  in Background)

     

     

Power

No. with data conservative

No. with data interventional

     

     

Notes:        

 

 

 

9.    Results

Copy and paste the appropriate table for each outcome, including additional tables for each time point and subgroup as required.

 

Dichotomous outcome – Early recurrence

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Comparison

     

     

Outcome

     

     

Subgroup

     

     

Timepoint
(post onset of pneumothorax)

     

     

Results

Conservative treatment

Interventional treatment

     

No. events

No. participants

No. events

No. participants

     

     

     

     

No. missing participants and reasons

     

     

     

No. participants moved from other group and reasons

     

     

     

Any other results reported

     

     

Unit of analysis(by individuals, cluster/groups or body parts)

 

     

     

Statistical methods used and appropriateness of these methods(e.g. adjustment for correlation)

     

     

Reanalysis required?(specify)

            

Yes      No     Unclear

     

     

Reanalysis possible?

            

Yes      No     Unclear

     

     

Reanalysed results

     

     

Notes:        

 

 

 

Repeat for late recurrence

 

Mortality

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Comparison

     

     

Outcome

     

     

Subgroup

     

     

Timepoint  
(time from onset of pneumothorax)

     

     

Results

Intervention

Comparison

     

No. events

No. participants

No. events

No. participants

     

     

     

     

No. missing participants and reasons

     

     

     

No. participants moved from other group and reasons

     

     

     

Any other results reported

     

     

Unit of analysis(by individuals, cluster/groups or body parts)

 

     

     

Statistical methods used and appropriateness of these methods(e.g. adjustment for correlation)

     

     

Reanalysis required?(specify)

            

Yes      No     Unclear

     

     

Reanalysis possible?

            

Yes      No     Unclear

     

     

Reanalysed results

     

     

Notes:        

 

 

 

Pleurectomy or pleurodesis

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Comparison

     

     

Outcome

     

     

Subgroup

     

     

Timepoint
(from onset of pneumothorax

     

     

Results

Intervention

Comparison

     

No. events

No. participants

No. events

No. participants

     

     

     

     

No. missing participants and reasons

     

     

     

No. participants moved from other group and reasons

     

     

     

Any other results reported

     

     

Unit of analysis(by individuals, cluster/groups or body parts)

 

     

     

Statistical methods used and appropriateness of these methods(e.g. adjustment for correlation)

     

     

Reanalysis required?(specify)

            

Yes      No     Unclear

     

     

Reanalysis possible?

            

Yes      No     Unclear

     

     

Reanalysed results

     

     

Notes:        

 

 

 

Complications

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Comparison

     

     

Outcome

     

     

Subgroup

     

     

Timepoint
(from onset of pneumothorax)

     

     

Results

Intervention

Comparison

     

No. events

No. participants

No. events

No. participants

     

     

     

     

No. missing participants and reasons

     

     

     

No. participants moved from other group and reasons

     

     

     

Any other results reported

     

     

Unit of analysis(by individuals, cluster/groups or body parts)

 

     

     

Statistical methods used and appropriateness of these methods(e.g. adjustment for correlation)

     

     

Reanalysis required?(specify)

            

Yes      No     Unclear

     

     

Reanalysis possible?

            

Yes      No     Unclear

     

     

Reanalysed results

     

     

Notes:        

 

 

 

Length of hospital stay

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Comparison

     

     

Outcome

     

     

Subgroup

     

     

Timepoint
(from admission)

     

     

Post‐intervention or change from baseline?

     

     

Results

Intervention

Comparison

 

Mean

SD (or other variance)

No. participants

Mean

SD (or other variance)

No. participants

     

     

     

     

     

     

     

No. missing participants and reasons

     

     

     

No. participants moved from other group and reasons

     

     

     

Any other results reported

 

     

     

Unit of analysis

(individuals, cluster/ groups or body parts)

     

     

Statistical methods used and appropriateness of these methods(e.g. adjustment for correlation)

     

     

Reanalysis required?(specify)

            

Yes      No     Unclear

     

     

Reanalysis possible?

            

Yes      No     Unclear

     

     

Reanalysed results

     

     

Notes:        

 

 

 

 

10. Applicability

 

Have important populations been excluded from the study?(e.g. smokers)

            

Yes      No     Unclear

     

Is the intervention likely to be aimed at disadvantaged groups?(e.g. lower socioeconomic groups)

            

Yes      No     Unclear

     

Does the study directly address the review question?

(any issues of partial or indirect applicability)

            

Yes      No     Unclear

     

Notes:        

 

 

11. Other information

 

 

Description as stated in report/paper

 

Location in text

(pg & ¶/fig/table)

Key conclusions of study authors

 

     

     

References to other relevant studies

 

     

     

Correspondence required for further study information(from whom, what and when)

     

Notes:        

 

 

Risk of Bias Table

Unique ID

 

ISDN

First author

Journal / conference

Year

Reviewer

 

 

 

 

 

 

 

 

Domain

Description of what was done

Risk of bias judgement

Sequence generation

(How were patients allocated into intervention groups)

 

Low     High     Unclear

Allocation concealment

(Was allocation list concealed prior to allocation)

 

Low     High     Unclear

Blinding of participants and personnel

(Bias due to knowledge of allocation by participant or personnel).

 

Low     High     Unclear

Blinding of outcome assessment  ‐ objective outcomes

(knowledge of the allocation by outcome assessor)

 

Low     High     Unclear

Blinding of outcome assessment – subjective outcomes

(knowledge of the allocation by outcome assessor)

 

Low     High     Unclear

Incomplete outcome data

(attrition due to amount, nature or handling of incomplete outcome data)

 

Low     High     Unclear

Selective reporting

(Are all pre‐specified outcomes reported)

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Risk of Bias Table

Unique ID

 

ISDN

First author

Journal / conference

Year

Reviewer

 

 

 

 

 

 

 

 

Domain

Description of what was done

Risk of bias judgement

Sequence generation

(How were patients allocated into intervention groups)

 

Low     High     Unclear

Allocation concealment

(Was allocation list concealed prior to allocation)

 

Low     High     Unclear

Blinding of participants and personnel

(Bias due to knowledge of allocation by participant or personnel).

 

Low     High     Unclear

Blinding of outcome assessment  ‐ objective outcomes

(knowledge of the allocation by outcome assessor)

 

Low     High     Unclear

Blinding of outcome assessment – subjective outcomes

(knowledge of the allocation by outcome assessor)

 

Low     High     Unclear

Incomplete outcome data

(attrition due to amount, nature or handling of incomplete outcome data)

 

Low     High     Unclear

Selective reporting

(Are all pre‐specified outcomes reported)

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Appendix 8. Risk of Bias Tool

Risk of Bias Table

Unique ID

 

ISDN

First author

Journal / conference

Year

Reviewer

 

 

 

 

 

 

 

 

Domain

Description of what was done

Risk of bias judgement

Sequence generation

(How were patients allocated into intervention groups)

 

Low     High     Unclear

Allocation concealment

(Was allocation list concealed prior to allocation)

 

Low     High     Unclear

Blinding of participants and personnel

(Bias due to knowledge of allocation by participant or personnel).

 

Low     High     Unclear

Blinding of outcome assessment  ‐ objective outcomes

(knowledge of the allocation by outcome assessor)

 

Low     High     Unclear

Blinding of outcome assessment – subjective outcomes

(knowledge of the allocation by outcome assessor)

 

Low     High     Unclear

Incomplete outcome data

(attrition due to amount, nature or handling of incomplete outcome data)

 

Low     High     Unclear

Selective reporting

(Are all pre‐specified outcomes reported)

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Other potential source of bias

 

 

Low     High     Unclear

Study flow diagram.
Figuras y tablas -
Figure 1

Study flow diagram.